Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  251 نتائج ل ""MESH: Receptor""

فلترة النتائج

Subject : mesh
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients

Subjects: MESH: Adolescent; MESH: Adult; MESH: Young Adult

  • Source: ISSN: 0006-4971.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The brain microvasculature is a primary mediator of interferon-α neurotoxicity in human cerebral interferonopathies

Subjects: Aicardi-Goutières syndrome; blood-brain barrier; cerebral interferonopathy

  • Source: ISSN: 1074-7613 ; Immunity ; https://pasteur.hal.science/pasteur-04646140 ; Immunity, 2024, 57 (7), pp.1696-1709.e10. ⟨10.1016/j.immuni.2024.05.017⟩.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases

Subjects: Breast cancer; Deruxtecan; Intrathecal

  • Source: ISSN: 0960-9776 ; The Breast ; https://hal.science/hal-04706560 ; The Breast, 2023, 69, pp.451-468. ⟨10.1016/j.breast.2023.04.008⟩.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

Subjects: MESH: Humans; MESH: Female; MESH: Ado-Trastuzumab Emtansine

  • Source: ISSN: 0140-6736.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Futibatinib, an Irreversible FGFR1–4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF / FGFR Aberrations: A Phase I Dose-Expansion Study

Subjects: MESH: Antineoplastic Agents; MESH: Bile Duct Neoplasms; MESH: Maximum Tolerated Dose

  • Source: EISSN: 2159-8290 ; Cancer Discovery ; https://hal.sorbonne-universite.fr/hal-04536934 ; Cancer Discovery, 2022, 12 (2), pp.402-415. ⟨10.1158/2159-8290.CD-21-0697⟩

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity

Subjects: latitude; melanocortin 1 receptor; multiple sclerosis

  • Source: ISSN: 0027-8424.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p

Subjects: DNMT3A; Exosomes; Extracellular vesicles

  • Source: ISSN: 0896-8411.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors

Subjects: MESH: Animals; MESH: Bone Neoplasms/genetics; MESH: Breast Neoplasms/metabolism

  • Source: ISSN: 0950-9232.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Melanocortin‐1 receptor ( MC1R ) genotypes do not correlate with size in two cohorts of medium‐to‐giant congenital melanocytic nevi

Subjects: population; phenotype; nevogenesis

  • Source: Pigment Cell & melanoma research ; https://hal.science/hal-03609329 ; Pigment Cell & melanoma research, 2020, 33 (5), pp.685-694. ⟨10.1111/pcmr.12883⟩

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Lipid metabolism and Calcium signaling in epithelial ovarian cancer

Subjects: MESH: Animals; MESH: Arachidonic Acid; MESH: Calcium Signaling

  • Source: ISSN: 0143-4160.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  251 نتائج ل ""MESH: Receptor""